Argitalpenak (206) Ikertzaileren baten partaidetza izan duten argitalpenak

2024

  1. Antifungal Synergy: Mechanistic Insights into the R-1-R Peptide and Bidens pilosa Extract as Potent Therapeutics against Candida spp. through Proteomics

    International Journal of Molecular Sciences, Vol. 25, Núm. 16

  2. Human gut microbiota analysis of cystic fibrosis infants using metaproteomics

    Microbiology Resource Announcements, Vol. 13, Núm. 6

  3. Immunotherapy in the Treatment of Advanced or Recurrent Endometrial Cancer

    Clinical Advances in Hematology and Oncology, Vol. 22, Núm. 3, pp. 129-139

  4. Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

    Clinical Cancer Research, Vol. 30, Núm. 5, pp. 975-983

  5. The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era

    Current Opinion in Obstetrics and Gynecology, Vol. 36, Núm. 2, pp. 104-111

  6. Unravelling the Role of Candida albicans Prn1 in the Oxidative Stress Response through a Proteomics Approach

    Antioxidants, Vol. 13, Núm. 5

2023

  1. Advances in immunotherapy for cervical cancer

    Therapeutic Advances in Medical Oncology, Vol. 15

  2. Advances in immunotherapy in cervical cancer

    International Journal of Gynecological Cancer, Vol. 33, Núm. 3, pp. 403-413

  3. Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior

    Stem Cell Research and Therapy, Vol. 14, Núm. 1

  4. Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review

    International journal of molecular sciences, Vol. 24, Núm. 18

  5. Oral disease is linked to low nestling condition and brood size in a raptor species living in a highly modified environment

    Current Zoology, Vol. 69, Núm. 2, pp. 109-120

  6. SILAC-Based Quantitative Phosphoproteomics in Yeast

    Methods in Molecular Biology (Humana Press Inc.), pp. 103-115

2022

  1. ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation

    International Journal of Gynecological Cancer, Vol. 32, Núm. 9, pp. 1196-1200

  2. Candida albicans Hyphal Extracellular Vesicles Are Different from Yeast Ones, Carrying an Active Proteasome Complex and Showing a Different Role in Host Immune Response

    Microbiology Spectrum, Vol. 10, Núm. 3

  3. Deciphering the Association among Pathogenicity, Production and Polymorphisms of Capsule/Melanin in Clinical Isolates of Cryptococcus neoformans var. grubii VNI

    Journal of Fungi, Vol. 8, Núm. 3

  4. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  5. Editorial: Tribute to Dr. Welda LaJean Chaffin - a legendary woman in fungal research

    Frontiers in Cellular and Infection Microbiology

  6. Fungal signatures of oral disease reflect environmental degradation in a facultative avian scavenger

    Science of the Total Environment, Vol. 837

  7. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 3, pp. 585-597

  8. Sample Processing for Metaproteomic Analysis of Human Gut Microbiota

    Methods in Molecular Biology (Humana Press Inc.), pp. 53-61